News|Articles|September 14, 2026

Case Study | How One Brand Used Automated Affordability to Reduce Patient Abandonment

Author(s)CoverMyMeds

Affordability can be the difference between a prescription written and a prescription filled. This case study examines how one brand's automated pharmacy affordability program helped reduce patient cost barriers and what happened when that support was temporarily removed, resulting in higher abandonment rates and fewer filled prescriptions.


Related to this article

Pharmaceutical Executive Daily
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.